The following article explores the novel coronavirus SARS-CoV-2, the global race to develop a vaccine and the many challenges faced by researchers during this unprecedented time. With a focus on the eight most promising vaccine candidates currently in clinical evaluation around the world, the results from the early stages of human trials are discussed and the difficulties faced by those at the forefront are brought to light.
